Summary The relationship between serum ceruloplasmin level and cancer incidence was investigated in a case-control study nested related to smoking were 3.9 (CI = 1.9-8.4) and 0.9 (CI = 0.6-1.5), respectively. The elevated risk of lung cancer at high concentrations of serum ceruloplasmin persisted after further adjustment for several potential confounding factors such as serum levels of vitamins A and E and selenium. The risk was stronger during the first 6 years of follow-up than later, and strongest during the first 2 years. The most likely explanation of the present results thus is that high serum ceruloplasmin levels in lung cancer are mainly due to occult cancer.
There is an association between high levels of serum copper and the occurrence of cancer. Case-control studies nested within cohort studies have reported an increased risk of cancer in persons with initially high serum concentrations of copper (Haines et al., 1982; Kok et al., 1988; Coates et al., 1989) . Elevated serum copper levels have also been found in patients suffering from cancers at such diverse sites as the breast, the lung, and gastrointestinal organs, and also in leukaemia, lymphoma and melanoma (Fisher, 1979) . Copper levels have been higher in patients with advanced disease than in those with less severe disease (Fisher, 1979) . The interpretation of this finding has been that elevated serum copper levels may be secondary to cancer. In line with this proposal one of the few cohort studies on serum copper and cancer reported an elevated risk of cancer death associated with high serum copper levels only during the first years of follow-up (Coates et al., 1989) . However, another study showed that the excess risk persisted longer (Kok et al., 1988) , suggesting that serum copper level may be raised for many years before diagnosis of the cancer.
The relation of copper to malignancy may be complex, however. In accordance with the hypothesis that copper may have an antioxidant effect and thus provide protection against cancer, an increased risk of cancer has also been observed in persons with low serum copper levels (Kok et al., 1988) . Furthermore, pharmacological doses of copper appear to protect experimental animals against chemically induced tumours (Committee on Diet ... 1982). Both deficiency and excess of copper may thus be potentially harmful, and the effects may not be similar for all sites of cancer (Molteni et al., 1989) . Not one of the few cohort studies conducted to date (Haines et al., 1982; Kok et al., 1988; Coates et al., 1989) (Willett, 1990 (Aromaa, 1981) . A self-completed questionnaire supplied information about occupation, previous and current illnesses, medications, parity and smoking habits. Height and weight were measured, and the body mass index (weight/height2) was computed. Casual blood pressure was recorded by the auscultatory method. Subjects with systolic blood pressure > 160 and diastolic blood pressure ) 95 mmHg, and those taking antihypertensive drugs, were described as hypertensive. The haematocrit level was determined by the Clay-Adams microhaematocrit method. Serum cholesterol concentrations were determined after 1-3 weeks of storage (at -20°C) with an autoanalyser modification of the Liebermann-Burchard reaction. The serum samples were kept at -20°C until they were thawed for ceruloplasmin, selenium, beta-carotene, retinol, retinol-binding protein and alpha-tocopherol analyses in 1983.
Information about incident cancer cases diagnosed during the follow-up between the date of examination and the end of December 1977 was obtained from the nationwide Finnish Cancer Registry (Teppo et al., 1980 The levels of retinol, beta-carotene and alpha-tocopherol in serum were determined simultaneously using high-pressure liquid chromatography (Aaran & Nikkari, 1988) . The concentration of serum selenium was determined by a graphite furnace atomic absorption spectrometric method (Alfthan & Kumpulainen, 1982) .
The correlation ratios between the serum ceruloplasmin level and various baseline characteristics in the control group were estimated using the general linear model (Cohen & Cohen, 1975) . The association between serum ceruloplasmin level and the risk of cancer was determined with the conditional logistic model (Breslow & Day, 1980) . Adjustment for potential confounding factors was performed by including them in the model. Relative risks (estimated as odds ratios) were computed for quintiles of adjusted serum ceruloplasmin levels. Statistical significances were tested with the likelihood ratio test based on the model.
Results
The mean levels of potential confounding factors among cases and controls are presented in Table I . There were more smokers among cancer cases than among controls, and the cases generally had lower levels of serum micronutrients than the controls. The female cases had fewer childbirths than the controls. Serum ceruloplasmin level was positively correlated with age, varied by geographical area, and was higher among smokers than among non-smokers in both sexes (Table II ).
The crude mean serum level of ceruloplasmin was 371 mg 1' among all male cancer cases, which was statistically significantly higher (P <0.001) than the mean of 354 mg 1`in the controls (Table III) . The difference between the cases and control means was greatest for lung cancer. Similar differences occurred for some other cancers related to (Table IV) . While little association was observed in women, there was a significant positive gradient in men between serum ceruloplasmin level and the occurrence of all sites of cancer, with a relative risk of 1.4 (95% confidence interval (CI) = 1.0-2.1) between the highest and lowest quintiles. The corresponding risks were greater for lung cancer and cancers related to smoking, i.e., 4.3 (CI = 1.8-10.6) and 3.9 (CI = 1.9-8.4), respectively. By contrast, the corresponding relative risk of cancers unrelated to smoking combined was 0.9 (95% confidence interval = 0.6-1.5). Adjustment for smoking, serum cholesterol, haematocrit, body mass index, occupation, parity in women, alpha-tocopherol, beta-carotene, retinol, retinol-binding protein and selenium did not materially change the results, the relative risk of lung cancer, smoking-related cancers combined and cancers unrelated to smoking combined being 3.5 (CI= 1.3-9.3), 3.9 (CI= 1.7-9.0), and 0.9 (CI=0.5-1.8), respectively.
No interaction between smoking and serum ceruloplasmin was observed. In fact, the relative risk of cancer was similar among non-smoking and smoking men in respect to cancers related to smoking and cancers unrelated to smoking (Table  V) . The number of current smokers among women was too small to give any reliable results.
In order to investigate whether the association between ceruloplasmin and cancer might be due to occult cancer, the association was studied separately for the first 6 years and the later years of follow-up (Table VI) . The significantly elevated risk of cancer at all sites, smoking-related cancers combined and lung cancer at high levels of serum ceruloplas- aThe quintiles are based on the distribution of values (mgl1') among controls (, 300, 301-330, 331-360, 361 -400, and > 401 in men and < 350, 351 -390, 391 -420, 421 -480, and ) min was mainly confined to the beginning of the follow-up and it was strongest during the first 2 years. In the first 2 years the relative risks of all sites of cancer, lung cancer, smoking-related cancers and cancers unrelated to smoking between the highest and lowest quintiles of serum ceruloplasmin were 2.7 (1.3-5.6), 12.9 (1.6-104.2), 7.4 (1.4-38.3), and 1.7 (0.7-4.0), respectively. On the other hand, a nonsignificant inverse association was observed during the later years of follow-up.
Discussion
In the present study, men initially free of cancer and with a high level of serum ceruloplasmin subsequently had an excess risk of cancer. This finding extends and corroborates those of previous cohort studies showing an elevated overall risk of cancer at high serum copper levels (Haines et al., 1982; Kok et al., 1988; Coates et al., 1989 (Solomons, 1985) . The indices of copper status are known to be sensitive to a number of external factors (Willett, 1990 ). Accordingly, serum ceruloplasmin level in the present study was associated with several potential confounders including nondietary factors such as smoking, body mass index, occupation and parity on the one hand, and nutrient-related factors such as serum cholesterol, retinol, beta-carotene, alpha-tocopherol and selenium on the other. Adjustment for these factors did not materially change the results, suggesting that the association between ceruloplasmin and cancer was not due to confounding by them. Nonetheless, the possibility of confounding by dietary, life-style and physiological factors not studied cannot be ruled out. Ceruloplasmin is one of the many 'acute phase reactant' proteins synthetised in the liver in response to various stimuli. Many of these internal and external stimuli resulting in liver disorders may be related to acute or chronic infections, and several other conditions, including malignancy, may similarly lead to increased synthesis of ceruloplasmin. Accordingly, the serum ceruloplasmin level has been reported to be raised in patients with cancer (Askari et al., 1980) , and to be higher in patients with advanced disease than among those with less severe disease (Fisher, 1979) . The results of the present study suggest that the presence of cancer may raise serum ceruloplasmin levels for several years before the cancer is diagnosed: in agreement with one previous cohort study (Coates et al., 1989) , the cancer risk at high serum ceruloplasmin levels was elevated mainly during the first 6 years of follow-up and the association was strongest during the first 2 years. An elevated serum ceruloplasmin level could thus be a marker for lung cancer, indicating the presence of this disease up to several years before it is diagnosed. An alternative interpretation is that high serum ceruloplasmin actually is a risk indicator preceeding the cancer. Thus, the positive association between serum ceruloplasmin level and cancer risk is, in fact, present over the entire follow-up, but is concealed during the last years of follow-up in the present study because of the relatively low long-term reliability of serum ceruloplasmin. This hypothesis is in agreement with the finding from another earlier study, reporting the excess risk associated with high serum copper level to have lasted for a long period (Kok et al., 1988) .
The association between copper and cancer may have other implications, too. In agreement with the hypothesis that copper may inhibit oxidative damage (Oberley & Buettner, 1979) , animal studies indicate that high doses of copper may provide protection against some cancers (Committee on Diet . . . 1982). Accordingly, in one of the previous studies (Kok et al., 1988) , a low level of copper was associated with a moderate increase in cancer mortality. A similar nonsignificant finding was observed in the present study after exclusion of the first 6 years of follow-up. Thus, the lack of an inverse association between the serum ceruloplasmin level and cancer risk in the total sample of the present study does not deny the possible importance of ceruloplasmin as an antioxidant in cancer causation and prevention. The results may merely reflect that the antioxidative effect of copper is concealed by the elevation of the seruim copper level due to occult cancer.
In conclusion, our findings suggest that high serum ceruloplasmin concentrations during few years before diagnosis are associated with an increased risk of cancer, especially of lung cancer. It is still conceivable that a high serum ceruloplasmin concentration is a risk indicator preceding cancer. However, the most likely explanation of the findings is that a high serum ceruloplasmin concentration is a sign of occult lung cancer. 
